Clinical Trials Browser

NIH × Hepatitis C × Clear all

NCT02772003 2026-03-19

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

Phase 1 Active not recruiting

Gastrointestinal

Hepatitis, Chronic, Hepatitis C, Carcinoma, Hepatocellular

NCT03520660 2026-03-11

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Phase 4 Active not recruiting

Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT02143401 2024-11-22

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

Gastrointestinal

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms

NCT01350648 2024-10-01

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

Gastrointestinal

Acquired Immunodeficiency Syndrome, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00341705 2019-12-17

The Second Multicenter Hemophilia Cohort Study

Classical hematologyGastrointestinalLymphoid

Acquired Immunodeficiency Syndrome, Hemophilia A, Hepatitis C, Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Neoplasms, Hepatic Insufficiency

NCT00825877 2019-12-17

Long-term Follow-up of HALT-C Sustained Virological Responders

Gastrointestinal

Ascites, Death, Hepatitis C, Carcinoma, Hepatocellular